“Towards FDA–USPTO Cooperation” by John R. Thomas – Scholarship @ GEORGETOWN LAW
The Food and Drug Administration (“FDA”) and U.S. Patent and Trademark Office (“USPTO”) play complementary roles in driving pharmaceutical …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Costa Rica signs historic validation agreement – European Patent Office
Costa Rica signs historic validation agreement European Patent Office
-
In: PATENT NEWS
Allele, Regeneron Settle COVID Treatment Patent Suit – Law360 UK
He also ruled that Regeneron wasn’t protected by a Hatch-Waxman Act safe harbor, which allows infringing activity when it’s related to preparing a …
-
In: PATENT NEWS
The State Of USPTO Rulemaking At The End Of Vidal’s Term – Law360
The State Of USPTO Rulemaking At The End Of Vidal’s Term Law360
-
In: PATENT NEWS
Allele, Regeneron Settle COVID Treatment Patent Suit – Law360
Allele, Regeneron Settle COVID Treatment Patent Suit Law360
-
In: PATENT NEWS
Rice welcomes opening patent appeal roadshow, offering rare Insights from patent judges
“Attendance was robust with patent attorneys, agents, examiners and inventors representing various law firms and corporations.” After the event …
-
In: PATENT NEWS
Rice welcomes opening patent appeal roadshow, offering rare Insights from patent judges – Rice News
Rice welcomes opening patent appeal roadshow, offering rare Insights from patent judges Rice News
-
In: PATENT NEWS
Regeneron settles patent lawsuit over protein for testing COVID-19 treatments – Reuters.com
Regeneron settles patent lawsuit over protein for testing COVID-19 treatments Reuters.com
-
In: PATENT NEWS
Ramey LLP Represents ORTIZ & ASSOCIATES CONSULTING, LLC in Patent Infringement …
… intellectual property rights. By filing this lawsuit, Ortiz … patent law. The case has been filed as a jury trial, signaling that …
-
In: PATENT NEWS
USPTO changes course on controversial proposed rule for terminal disclaimers
Obviousness-type double patenting is a judicially created doctrine preventing improper extension of patent rights by obtaining a second patent for an …